WKN DE: A2AJKS / ISIN: FR0013154002

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (groß)	News + Adhoc	Bilanz/GuV	Termine	Zertifikate	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Optionsscheine	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV		Knock-Outs
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime
Kurs + Chart
Chart (groß)
Times + Sales
Chartvergleich
Börsenplätze
Realtime Push
Orderbuch
Historisch

News + Analysen
News + Adhoc
Analysen
Kursziele

Fundamental
Bilanz/GuV
Schätzungen
Dividende/GV
Analysen

Unternehmen
Termine
Profil

zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs

Aktion
Portfolio
Watchlist

Sartorius Stedim Biotech Times and Sales (STU)

Zeit	Kurs	Umsatz (Stk)	Umsatz grafisch
Times and Sales Zur Zeit stehen keine Daten zur Verfügung

Kursrückgang	Kursanstieg	keine Kursänderung
(Balkenlänge beschreibt das Umsatzvolumen)

Nachrichten zu Sartorius Stedim Biotech

24.03.26		Resolutions of the Combined Annual Shareholders’ Meeting of Sartorius Stedim Biotech S.A.
17.03.26		Sartorius Stedim Biotech sharpens strategy with biopharma focus and sets new mid-term growth targets
06.03.26		ANALYSE-FLASH: RBC hebt Sartorius Stedim Biotech auf 'Outperform' - Kaufchance
16.02.26		Sartorius Stedim Biotech releases Universal Registration Document 2025
16.02.26		Sartorius Stedim Biotech releases Universal Registration Document 2025
06.02.26		Board of Directors of Sartorius Stedim Biotech S.A. resolves dividend proposal of 0.69 euros
03.02.26		Sartorius Stedim Biotech achieves considerable profitable growth in 2025 and maintains positive outlook
02.02.26		Ausblick: Sartorius Stedim Biotech stellt Quartalsergebnis zum abgelaufenen Jahresviertel vor
19.01.26		Erste Schätzungen: Sartorius Stedim Biotech stellt Quartalsergebnis zum abgelaufenen Jahresviertel vor

Analysen zu Sartorius Stedim Biotech

20.03.26	Sartorius Stedim Biotech Overweight
18.03.26	Sartorius Stedim Biotech Overweight
18.03.26	Sartorius Stedim Biotech Outperform
18.03.26	Sartorius Stedim Biotech Overweight
17.03.26	Sartorius Stedim Biotech Buy

Weitere Meldungen

10:06		Here's Why The Vanguard S&P 500 Growth ETF Could Be Your Ticket to Beating the Market Over the Long Term
10:03		In an Asymmetrical War, Iran Seeks an Edge With Its Information War
10:01		Smaller Is Better in Silicon Valley’s ‘Tiny Team’ Moment
10:00		Today's Wordle Hints, Answer and Help for March 28, #1743
10:00		Can This Russian Bakery Survive a 3,500% Tax Increase?
09:44		Better Energy Stock: Brookfield Renewable vs. Enterprise Products Partners
09:42		Is Now the Time to Buy Salesforce? Here's What the Numbers Reveal
09:07		India: Modi inaugurates new international airport in Noida
08:48		The Nasdaq Just Hit Correction Territory. History Says the Stock Market Will Do This Next (Hint: It May Shock You).
08:46		This Move Could Protect Your Retirement Savings Big Time in 2026
08:45		Prediction: The Trump Bull Market Is About to End -- but These Stocks Will Rise Anyway
08:22		BlackRock CEO Larry Fink's Pay Jumps To $37.7 Million In 2025 As Managed Assets Hit Record $14 Trillion
08:12		Gene Munster Says Upcoming Tesla Deliveries Will Be 'First Good Read,' As Ford, GM Scale Back EV Ambitions— Here's Why
08:02		The First Blockbuster Stock Split of 2026 Is Just Days Away. The Stock Skyrocketed 30,490% in 25 Years and Has More Upside Ahead, According to Wall Street
07:59		Tiger Woods released on bail after Florida car crash
07:55		India: Modi to inaugurate new international airport in Noida
07:47		Free prom hire boutique set up for two schools
07:30		There Are 10 Trillion-Dollar Stocks On the Market. This Is the Only One That's Up This Year
07:17		How will energy crisis hit Ireland's economy?
06:17		David Sacks Slams Anthropic As 'Ruthless' Amid Pentagon Clash: 'They're Not Always On The Side Of The Angels'
05:44		Trump Orders DHS To Immediately Pay TSA Workers— 50,000 Frontline Officers To Receive Checks From As Early As Monday
05:39		Bank of America settles Epstein case for $72.5 million
05:13		Europe: Shares fall as mixed Middle East signals cloud outlook
05:01		Marco Rubio Says US-Iran War To End In 'Weeks, Not Months' And No Ground Troops Needed
04:53		US: Stocks tumble, Dow confirms correction territory, as Middle East tensions drag
04:45		Elizabeth Warren Slams Trump's 'Corporate Pardon' Of Ticketmaster, Cites Taylor Swift, Olivia Dean's Criticism: 'We've Got To...'
04:01		Is Celsius Stock a Buy After Falling 49% From Its 52-Week High?
03:59		Iran war: US troops wounded in strike on Saudi base
02:47		Lincoln Educational Insider Sells 8,450 Shares Amid Big Stock Surge, but Here's What Matters for Investors
02:43		Why Six Flags Stock Fell Today
02:30		Progress Software EVP Sells 23,194 Shares as Stock Falls 40% Year Over Year
02:30		Meta Plunges on Jury Verdict. Here's What It Means for Investors
02:23		AXT's CEO Sold Shares Worth $1.4 Million. Is Now the Time to Sell or Buy the Stock?
02:13		Bank of America to Pay $72.5 Million to Settle Lawsuit by Epstein Victims
02:12		Alpha Metallurgical Insider Purchase Worth $2 Million Comes Just Weeks Before 20% Rally
02:00		Carnival Gets Hit By the Iran War. Can the Cruise Stock Bounce Back?
01:46		Is Tecnoglass Stock a Buy After Energy Holdings Scooped Up Shares Worth $13.1 Million?
01:32		Stoke Therapeutics Stock Up 340% as Chair Sells $174K in Shares
01:19		This F&G Insider Spent $100,000 Buying Shares Despite a Steep Stock Plunge. Is It Time for a Turnaround?
01:17		Should You Buy Lockheed Martin While It's Up 26% in 2026?
01:15		Why Argan Stock Ascended Today
01:06		LeMaitre Vascular Up 30% as Insider Sells $285K in Stock. Here's What Investors Should Know
00:47		Alphatec CFO Sells $986K in Stock With Shares Up 9% This Past Year. Here's What Investors Should Know
00:45		If You Invested $1000 In Fortinet Stock 5 Years Ago, You Would Have This Much Today
00:32		Why Corcept Therapeutics Zoomed Nearly 9% Higher This Week
00:32		The Market Is Down 5% in 2026. Here's the Best Dividend Stock to Buy With $10,000 Right Now.
00:31		Here's How Much $100 Invested In FormFactor 10 Years Ago Would Be Worth Today
00:20		Ligand Pharma CFO Sells $688K in Stock as Shares Surge 80% This Past Year. Here's What to Know
00:18		The 1 Retirement Budgeting Mistake Too Many People Risk Making
00:15		If You Invested $100 In e.l.f. Beauty Stock 5 Years Ago, You Would Have This Much Today

Zurück | 1 | 2 | 3 | Weiter

finanzen.net Apps

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.

JETZT MEHR ERFAHREN

Aktien ATX DAX EuroStoxx 50 Dow Jones NASDAQ 100 Nikkei 225 S&P 500

Weitere Aktien: IBERIABANK Oncobiologics Zhejiang Langdi Group Voicetel Communications Intellia Therapeutics

Kontakt - Impressum - Werbung - Barrierefreiheit

Sitemap - Datenschutz - Disclaimer - AGB - Privatsphäre-Einstellungen

Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Financial Information Deutschland GmbH. Verzögerung 15 Min. (Nasdaq, NYSE: 20 Min.).
© 1999-2026 finanzen.net GmbH

*Werbehinweise: Die Billigung des Basisprospekts durch die Bundesanstalt für Finanzdienstleistungsaufsicht ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.

⁵Hinweis zu Plus500: 79% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren. Plus500UK Ltd ist zugelassen und reguliert durch Financial Conduct Authority (FRN 509909). Plus500CY Ltd authorized & regulated by CySEC (#250/14).

Währungsrechner News Devisen Dollarkurs Aktienkurse Bitcoin Rohstoffe Fonds

Portfolioname: Watchlistname:
Portfolio:
Name:
Typ:
ISIN:
Börse:
Anzahl:
Aktueller Kurs:
Kurszeit:
Kaufpreis:
Kaufdatum:	28.03.2026 22:57
Kaufwert:	EUR
	Hinzufügen Speichern

Sartorius Stedim Biotech Aktie

WKN DE: A2AJKS / ISIN: FR0013154002

Sartorius Stedim Biotech Times and Sales (STU)

Times and Sales

Nachrichten zu Sartorius Stedim Biotech

Analysen zu Sartorius Stedim Biotech

Weitere Meldungen